Literature DB >> 25879476

Smoking cessation after 12 months with multi-component therapy.

Antònia Raich1, Jose Maria Martínez-Sánchez, Emili Marquilles, Lídia Rubio, Marcela Fu, Esteve Fernández.   

Abstract

Smoking is one of the most important causes of morbidity and mortality in developed countries. One of the priorities of public health programmes is the reduction of its prevalence, which would involve millions of people quitting smoking, but cessation programs often have modest results, especially within certain population groups. The aim of this study was to analyze the variables determining the success of a multicomponent therapy programme for smoking cessation. We conducted the study in the Smoking Addiction Unit at the Hospital of Manresa, with 314 patients (91.4% of whom had medium or high-level dependency). We observed that higher educational level, not living with a smoker, following a multimodal programme or smoking cessation with psychological therapy, and pharmacological treatment are relevant factors for quitting smoking. Abstinence rates are not associated with other factors, such as sex, age, smoking behaviour characteristics or psychiatric history. The combination of pharmacological and psychological treatment increased success rates in multicomponent therapy. Psychological therapy only also obtained positive results, though somewhat more modest.

Entities:  

Mesh:

Year:  2015        PMID: 25879476

Source DB:  PubMed          Journal:  Adicciones        ISSN: 0214-4840            Impact factor:   2.979


  2 in total

1.  Premenstrual symptoms and smoking-related expectancies.

Authors:  Raina D Pang; Mariel S Bello; Matthew D Stone; Matthew G Kirkpatrick; Jimi Huh; John Monterosso; Martie G Haselton; Melissa R Fales; Adam M Leventhal
Journal:  Addict Behav       Date:  2016-02-02       Impact factor: 3.913

2.  Implementation of a quality improvement project on smoking cessation reduces smoking in a high risk trauma patient population.

Authors:  Jeffry Nahmias; Andrew Doben; Shiva Poola; Samuel Korntner; Karen Carrens; Ronald Gross
Journal:  World J Emerg Surg       Date:  2016-04-26       Impact factor: 5.469

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.